Sensitivity (PPA)


Specificity (NPA)

Results in minutes

In Vitro Diagnostic Test by CELLEX

Rapid Screen for COVID-19

The Cellex qSARS-CoV-2 IgM/IgG Rapid Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma, or venipuncture whole blood samples. Similar to a home pregnancy test, the test produces results within 20 minutes.

How accurate is this test?
The sensitivity is 96% and the specificity is 93.8%. No test is 100%!
Are these tests covered by insurance?
The CMS CPT code is 86318. The individual’s insurance should be consulted to determine reimbursement
Are these tests approved under the FDA's EUA?
Yes, Cellex qSARS-CoV-2 IgG/IgM was granted approval under the EUA on June 12th, 2020
I would like to order. Who do I contact?
Contact your WMG Sales Representative or call 404-383-4099. Most orders can be shipped within 48 hours.